Document Detail

Heparin therapy during pregnancy. Risks to the fetus and mother.
MedLine Citation:
PMID:  2802889     Owner:  NLM     Status:  MEDLINE    
The true maternal and fetal risks of heparin therapy during pregnancy are unknown, because most published studies are small and do not report consecutively treated patients. In order to address these issues, we performed a retrospective cohort study of 100 pregnancies in 77 women treated with heparin during pregnancy. In 98 pregnancies heparin therapy was given for the prevention or treatment of venous thromboembolism; in the remaining 2, because of prosthetic heart valves. The rates of prematurity, abortions, stillbirths, neonatal deaths, and congenital abnormalities were similar to those in the normal population. There were two bleeding episodes and no symptomatic thrombotic episodes associated with heparin therapy. We conclude that maternal heparin therapy is safe for the fetus and is associated with an acceptable bleeding rate and a low rate of thrombotic recurrence in the mother.
J S Ginsberg; G Kowalchuk; J Hirsh; P Brill-Edwards; R Burrows
Related Documents :
8562839 - Thrombocytopenia, antithrombin deficiency and extensive thromboembolism in pregnancy: t...
2546279 - Low molecular weight heparin novo (lhn-1) does not cross the placenta during the second...
1495719 - Axillary vein thrombosis during pregnancy: a case report.
12420239 - Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
22039029 - Perinatal outcomes in twin pregnancies with discordant doppler velocimetric findings.
15725079 - Low molecular weight heparin in pregnancy: current issues.
7509759 - Diagnosis of intrauterine and ectopic pregnancy at 5-7 postmenstrual weeks.
7307289 - Oestrogen stimulated neurophysin in pregnancy and lactation.
7503809 - Aortic stenosis, cesarean delivery, and epidural anesthesia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of internal medicine     Volume:  149     ISSN:  0003-9926     ISO Abbreviation:  Arch. Intern. Med.     Publication Date:  1989 Oct 
Date Detail:
Created Date:  1989-11-09     Completed Date:  1989-11-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372440     Medline TA:  Arch Intern Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2233-6     Citation Subset:  AIM; IM    
Department of Medicine, McMaster University, Hamilton, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abnormalities, Drug-Induced
Cohort Studies
Heart Valve Prosthesis
Heparin / adverse effects,  therapeutic use*
Obstetric Labor, Premature / chemically induced
Pregnancy Complications, Cardiovascular / drug therapy*
Pregnancy Outcome
Retrospective Studies
Thromboembolism / drug therapy
Uterine Hemorrhage / chemically induced
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prospective study of Candida endophthalmitis in hospitalized patients with candidemia.
Next Document:  The impact of the prospective payment system on the treatment of hip fractures in the elderly.